Bin Zhao

6PUBLICATIONS
5CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)PharmacogenomicsCheminformatics and quantitative structure-activity relationshipsMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 02, 2025
Comprehensive safety assessment of ribociclib: A real-world analysis using the FDA Adverse Event Reporting System (FAERS) database.

Lan Luo, Yue Wang, Yumei Fu

|Sep 28, 2024
A real-world pharmacovigilance study using disproportionality analysis of United States Food and Drug Administration Adverse Event Reporting System events for vinca alkaloids: comparing vinorelbine and Vincristine.

Cheng Zhong, Qi Zheng, Bin Zhao

|Jul 31, 2024
A real-world disproportionality analysis of cyclosporine from the FDA Adverse Event Reporting System (FAERS) database.

Shichao Cui, Li Li, Wensheng Liu

|Jul 08, 2023
A real-world data analysis of acetylsalicylic acid in FDA Adverse Event Reporting System (FAERS) database.

Bin Zhao, Xiaohong Zhang, Moliang Chen

|May 27, 2023
A real-world data analysis of topotecan in the FDA Adverse Event Reporting System (FAERS) database.

Haiyan Yang, Zheng Wan, Moliang Chen

|Mar 31, 2019
Weighted correlation network and differential expression analyses identify candidate genes associated with BRAF gene in melanoma.

Bin Zhao, Yanqiu You, Zheng Wan

Pageof 1

Frequent Collaborators

1 joint publications

Shichao Cui

1 joint publications

Li Li

1 joint publications

Wensheng Liu

1 joint publications

Xingming Zhong